Alkermes (ALKS) Misses Q1 EPS by 18c
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q1 EPS of $0.13, $0.18 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $306.5 million versus the consensus estimate of $309.51 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- H.C. Wainwright Reiterates Buy Rating on Tvardi Therapeutics Inc (TVRD)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
